Cardiomyopathy Trial, Recruiting NCT05662293 Sponsor: University Hospital, Basel, Switzerland Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT05662293
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the forward-looking (prospective) part of the study:

  • You have been diagnosed with, or are suspected to have, a heart condition caused by an irregular heartbeat (arrhythmia-induced cardiomyopathy), based on your medical records or a referral from a heart or internal medicine specialist
  • You are willing and able to sign a consent form to take part in the study

For the backward-looking (retrospective) part of the study:

  • Your medical records from 2010–2021 show that your heart's pumping ability was significantly reduced, and you were also diagnosed with an irregular heartbeat around the same time (within one year before or after)

Who may not be able to join:

  • Anyone under 18 years of age
  • Anyone who has refused the general consent policy of the University Hospital Basel
  • Anyone who is currently seriously unwell — for example, having a heart attack, severe infection (sepsis), major injury, recent heart surgery, or a state of medical shock (confirm with trial site)
  • Anyone whose life expectancy is less than one year, such as those receiving end-of-life or palliative care for advanced cancer
  • Anyone whose reduced heart pumping ability was clearly caused by a sudden, severe event such as a major heart attack, cardiac arrest, or severe shock from another cause (for the retrospective part)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Patrick Badertscher, MD, University Hospital Basel, Department of Cardiology

Phone: +41 61 556 58 23

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Basel, Switzerland
Registry
ClinicalTrials.gov
Start date
10 June 2021
Est. completion
1 January 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Incidence of AiCM (retrospective part of the study); Incidence of AiCM (Prospective part of the study); Change in Major adverse cardiovascular events (MACE) assessment questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov